Target intelligence / Profile preview

PYY, Insulin, and Thermogenesis Signaling Pathways

Molecular classification
Signaling pathway, Hormonal system
01

Overview

The PYY, Insulin, and Thermogenesis Signaling Pathways represent a coordinated physiological network responsible for maintaining energy homeostasis. Peptide YY (PYY), specifically the PYY3-36 isoform, is secreted by intestinal L-cells in response to food intake and acts as a satiety signal by binding to the Neuropeptide Y receptor type 2 (Y2R) in the arcuate nucleus of the hypothalamus (PMID: 12110890). Insulin, while primarily known for its role in peripheral glucose disposal via the insulin receptor, also acts centrally to inhibit appetite and can influence thermogenic activity in brown adipose tissue (BAT) (PMID: 24119848). Thermogenesis is the process of heat production, largely mediated by Uncoupling Protein 1 (UCP1) in BAT, which uncouples oxidative phosphorylation from ATP production to dissipate energy as heat (PMID: 11316783). Dysregulation within these intersecting pathways is a hallmark of obesity and metabolic disorders, making them a primary focus for multi-receptor agonist therapies aimed at simultaneous appetite suppression and increased caloric expenditure.

Other names
Energy homeostasis signaling networkMetabolic regulatory pathwaysAppetite and thermogenic signaling
02

Mechanism of action

Modulation of energy balance through the activation of Neuropeptide Y receptor type 2 (Y2R) by PYY to induce satiety, the activation of the Insulin Receptor (INSR) to regulate glucose uptake and central energy signaling, and the stimulation of Uncoupling Protein 1 (UCP1) in brown adipose tissue to increase energy expenditure via thermogenesis.

03

Biological functions

Energy homeostasisAppetite regulationGlucose metabolismThermogenesisLipid metabolism
04

Disease associations

ObesityType 2 diabetesMetabolic syndromeInsulin resistance
05

Safety considerations

HypoglycemiaGastrointestinal distress (nausea/vomiting)Cardiovascular strain from thermogenic activationPotential for weight rebound upon cessation
06

Interacting drugs

Insulin

6 more in the full profile.

07

Biomarkers

Blood glucose levelsHbA1cCirculating PYY levelsResting energy expenditure (REE)Brown adipose tissue (BAT) activity via PET-CT

Beyond the preview

Go deeper on PYY, Insulin, and Thermogenesis Signaling Pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PYY, Insulin, and Thermogenesis Signaling Pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call